The 9th annual Lancet–Chinese Academy Medical Sciences (CAMS) health conference highlighted China’s outstanding research contributions, encouraged global collaboration, and emphasized significant health challenges, with a particular focus on the escalating issue of non-communicable diseases (NCDs) there. Speakers unveiled concerning evidence indicating substantial gaps in NCD services in China, showcasing the monumental burden the country is grappling with. Lei Zhang’s (Xian Jiaotong University) projections illustrated the economic toll of diabetes surpassing the GDP growth rate from 2020 to 2030. This aligns with existing data indicating a surge in diabetes cases from 35.5 million in 1990 to 118 million in 2021, projected to skyrocket to 257 million by 2050. Winnie Yip (Harvard University) highlighted a rise in hypertension prevalence from 25.7% in 2007 to 31.5% in 2017, revealing that only 34.2% of those with hypertension were treated, and a mere 9.2% had their blood pressure effectively controlled. Xi Li’s (CAMS) data exposed significant disparities in hypertension awareness, treatment, and control across primary care settings in China.1

Read more here.

References

  1. Lancet. (2023b). Non-communicable diseases in China: a rising tide. The Lancet, 402(10417), 2045. https://doi.org/10.1016/s0140-6736(23)02691-0

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred